[go: up one dir, main page]

AU2001296247A1 - Cysteine protease inhibitors - Google Patents

Cysteine protease inhibitors

Info

Publication number
AU2001296247A1
AU2001296247A1 AU2001296247A AU9624701A AU2001296247A1 AU 2001296247 A1 AU2001296247 A1 AU 2001296247A1 AU 2001296247 A AU2001296247 A AU 2001296247A AU 9624701 A AU9624701 A AU 9624701A AU 2001296247 A1 AU2001296247 A1 AU 2001296247A1
Authority
AU
Australia
Prior art keywords
protease inhibitors
cysteine protease
cysteine
inhibitors
protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296247A
Inventor
Bernard L. Hirschbein
James T. Palmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axys Pharmaceuticals Inc
Original Assignee
Axys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axys Pharmaceuticals Inc filed Critical Axys Pharmaceuticals Inc
Publication of AU2001296247A1 publication Critical patent/AU2001296247A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/107—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with two aryl or substituted aryl radicals attached in positions 2 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001296247A 2000-09-12 2001-09-11 Cysteine protease inhibitors Abandoned AU2001296247A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23178700P 2000-09-12 2000-09-12
US60231787 2000-09-12
PCT/US2001/028714 WO2002023784A2 (en) 2000-09-12 2001-09-11 Cysteine protease inhibitors

Publications (1)

Publication Number Publication Date
AU2001296247A1 true AU2001296247A1 (en) 2002-03-26

Family

ID=22870646

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296247A Abandoned AU2001296247A1 (en) 2000-09-12 2001-09-11 Cysteine protease inhibitors

Country Status (2)

Country Link
AU (1) AU2001296247A1 (en)
WO (1) WO2002023784A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002080920A1 (en) * 2001-04-06 2002-10-17 Axys Pharmaceuticals, Inc. Arylacetamido-ketobenzoxazole as cysteine protease inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000051998A1 (en) * 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
US7144901B2 (en) * 1999-12-03 2006-12-05 Ono Pharmaceutical Co.,Ltd. Oxadiazole derivatives and drugs containing these derivatives as the active ingredient

Also Published As

Publication number Publication date
WO2002023784A2 (en) 2002-03-21
WO2002023784A3 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
AU2002305926A1 (en) Cysteine protease inhibitors
GB0125445D0 (en) Protease Inhibitors
IL150964A0 (en) Protease inhibitors
AU6007200A (en) Cysteine protease inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU2001269836A1 (en) Proteases
AU2001247589A1 (en) Non-amidine containing protease inhibitors
AU2001285750A1 (en) Urokinase inhibitors
AU3570000A (en) Substituted azetidin-2-ones as cysteine protease inhibitors
IL139187A0 (en) Cysteine protease inhibitors
AU2003234630A1 (en) Cysteine protease inhibitors
AU2002232681A1 (en) Activity-dependent cysteine protease profiling reagent
IL153421A0 (en) Protease inhibitors
AU2560700A (en) Acylated aminoacetonitriles as cysteine protease inhibitors
AU2002239753A1 (en) Proteases
AU2001247483A1 (en) Proteases
AU1588901A (en) Protease inhibitors
IL151087A0 (en) Protease inhibitors
AU1474801A (en) Protease inhibitors
AU2002242500A1 (en) Cathepsin cysteine protease inhibitors
AU1039801A (en) Compounds and their use as cysteine protease inhibitors
AU1474701A (en) Protease inhibitors
AU4066900A (en) Protease inhibitors
AU3888200A (en) Protease inhibitors
AU1474601A (en) Protease inhibitors